SlideShare a Scribd company logo
2
Most read
7
Most read
17
Most read
DIABETIC KETOACIDOSIS IN
CHILDREN
D:MH RADI
SENIOR REGESTRAR OF PEDIATRICS
DEFINITION
• Hyperglycemia BG > 200 mg/dl (11 mmol/l)
(young or partially treated children, pregnant adolescents may present with
“euglycemic ketoacidosis”)
• Venous pH <7.3 and/or bicarbonate <15 mmol/L
• mild DKA pH <7.3 bicarbonate <15
• moderate pH <7.2 bicarbonate <10
• severe pH <7.1 bicarbonate < 5
• Glucosuria and ketonuria/ketonemia (β-HOB)
INCIDENCE OF DKA AT ONSET
• Wide geographic variation in DKA rates at diabetes
onset: 15 -70%
• More common in developing countries
• DKA rates inversely related to incidence of type 1
diabetes
RISK FACTORS FOR DKA AT ONSET
• Age <12 yrs
• No first degree diabetic relative
• Lower socioeconomic status
• High dose glucocorticoids, atypical antipsychotics,
diazoxide and some immunosuppresive drugs
• Poor access to medical care
DKA IN CHILDREN WITH ESTABLISHED T1DM
• The risk of DKA varies from 1:10 to 1:100 /p-yr
• Poor metabolic control or previous DKA  risk
• Adolescent girls
• Children with psychiatric disorders, including those
with eating disorders
• Lower socio-economic status
• Inappropriate interruption of insulin pump therapy
PROPORTION OF CHILDREN WITH RECURRENT
DKA
0 1 2+
• 60% of DKA episodes
occurred in 5% of
children who had 2 or
more events
# of DKA events
5%
Diabetes Care 2006 29:1150-1159
SIGNS OF DKA
• Vomiting
• Increased urination
• Abdominal pain
• Fruity odor to breath
• Dry mouth and tongue
• Drowsiness
• Deep breathing
• Coma
• Death
PHYSICAL EXAM
• Perfusion
• Vital Signs - including weight
• Hydration
• Mental Status
• Evidence for insulin resistance
CEREBRAL EDEMA
• Know what to look for
• Altered mental status/ severe headache
• Recurrence of vomiting
• Changes in pupil size, seizures, bradycardia
• Clinical worsening despite improving lab values
• CT/ MRI changes may not be seen in early cerebral edema
TIME OF ONSET OF NEUROLOGICAL COMPROMISE
(HOURS)
0
2
4
6
8
10
12
14
16
0-2.9 3-5.9 6-8.9 9-11.9 12-14.9 >15
# of
patients
Muir A, et al, Diab Care. July 2004
Timing of Onset of Cerebral Edema in DKA
CALCULATIONS
SERUM OSMOLALITY:
2[NA+K]+ (GLUCOSE/18) + BUN/2.8
SERUM NA:
CORRECTED NA =
MEASURED NA + (1.6)(GLUCOSE - 100)/100
ANION GAP:
[NA] – ([CL]+[HCO3])
NORMALLY 12+/-2 MMOL/L
TREATMENT
• Consider ICU admission for closer monitoring if:
• Severe DKA (pH < 7.1 or < 7.2 in young child)
• Altered level of consciousness
• Under age of 5 years
• Increased risk for cerebral edema
• Caution with meds that may alter mental status
TREATMENT
Monitoring
• Management requires close attention to detail
• Use a flowsheet to track vital signs labs, rates of
insulin, fluids, dextrose
• Neurological status
• consider neuro checks q 1 hr
• How does the patient look TO YOU?
• Assess, reassess and then assess again
FLUID THERAPY FOR DKA
• Assume 10-15% dehydration
• Begin with a 10-20 ml/kg bolus of NS
• Replace calculated deficit evenly over 36-48
hours
• Do not exceed 40ml’s/kg in the initial 4 hours, or
4 L/m squared in 24 hours
DKA - FLUIDS
• START BY ½ NS
• K supplementation
20mEq/L K Acetate + 20mEq/L K Phosphate
• Ionized calcium is low, phosphorous should not be given
• early replacement and frequent monitoring
• Bicarbonate therapy is rarely, if ever, indicated
INSULIN THERAPY FOR DKA
• IV infusion with basal rate 0.1 U/kg/hr
• No initial insulin bolus – it will decrease time to correction of the
glucose, but does not alter the time to correction of acidosis
It may decrease the serum osmolality more rapidly than desirable
• Ideal glucose decline is about 100 mg%/hr
• Continue insulin until urinary (blood) ketones are cleared
POTASSIUM
• Add potassium when K< 5 and with urination
• K >5.5 – no potassium in IVF
• K 4.5 – 5.5 – 20 meq/L K+
• K <4.5 – 40 meq/L K+
USE OF BICARBONATE IN DKA
• Bicarbonate should be used only when
there is severe depression of the
circulatory system or cellular metabolism...
• Not recommended unless pH <7.0, not even then, unless above true
TREATMENT OF CEREBRAL EDEMA
• Mannitol: 1 gram/ kg IV over 30 minutes
• Elevate the head of the bed
• Decrease IVF rate and insulin infusion rate
• Pediatric ICU management
• Do not delay treatment until radiographic evidence
SUCCESSFUL MANAGEMENT
• Careful attention to detail
• Careful record keeping
• A detailed flow chart is essential
• Following the data recorded is also essential
• Repeated examination of the patient
THANK YOU

More Related Content

PPTX
Dibetic Ketoacidosis in Children
PDF
Dka management in children
PPTX
Diabetic Ketoacidosis in Children (DKA)
PPT
Diabetic keto acidosis in children ... Dr.Padmesh
PPT
Pediatrics DKA slide set updated
PPT
Dehydraton in pediatrics
PPTX
Approach to cyanotic congenital heart disease
PPTX
Spina bifida Neurological disorder
Dibetic Ketoacidosis in Children
Dka management in children
Diabetic Ketoacidosis in Children (DKA)
Diabetic keto acidosis in children ... Dr.Padmesh
Pediatrics DKA slide set updated
Dehydraton in pediatrics
Approach to cyanotic congenital heart disease
Spina bifida Neurological disorder

What's hot (20)

PPTX
Pediatric urinary tract infection
PDF
Seizures in children 2021
PPTX
PPTX
Microcephaly & Macrocephaly
PPTX
Acute kidney injury in children 2018
PDF
SHORT STATURE
PPT
Failure to thrive
PPT
Pediatric hypoglycemia
PPTX
Pediatric hypertension
PPTX
Coma in pediatric
PPT
Neonatal hypoglycemia
PPTX
Hypoglycemia in children
PPTX
Hyponatremia in children
PPTX
Acute kidney injury in pediatrics
PPTX
Nephrotic Syndrome in Pediatrics
PDF
Chronic liver disease in children 2021
PPTX
Seizure Disorders in Children
PPTX
Meningitis in children
PPTX
Kawasaki disease
PPTX
Neonatal sepsis
Pediatric urinary tract infection
Seizures in children 2021
Microcephaly & Macrocephaly
Acute kidney injury in children 2018
SHORT STATURE
Failure to thrive
Pediatric hypoglycemia
Pediatric hypertension
Coma in pediatric
Neonatal hypoglycemia
Hypoglycemia in children
Hyponatremia in children
Acute kidney injury in pediatrics
Nephrotic Syndrome in Pediatrics
Chronic liver disease in children 2021
Seizure Disorders in Children
Meningitis in children
Kawasaki disease
Neonatal sepsis
Ad

Similar to DKA in children (20)

PPTX
DKA by Dr. A. Mandour.pptx
PPTX
dkadrsyed2584-190602083813 (1).pptx
PPTX
Diabetic Ketoacidosis
PDF
dkadrsyed2584-190602083813 (1).pdf
PPTX
PPTX
DKA Presentation in ICU.................
PPTX
DKA Discussion Paediatrics.pptx
PDF
Diabetes+ketoacidosis
PPTX
Presentation on diabetic Ketoacidosis DKA.pptx
PPTX
DKA and HHS Abdullah Bani Issa aaaa.pptx
PPTX
Hyperglycemic emergencies
PPTX
DIABETIC KETOACIDOSIS. and ISPAD classification
PPTX
Diabetic Ketoacidosis management in pediatrics
PPTX
DM medical emergencies 25-10-2023.pptx
PPT
Dka diabetic ketoacidosis managment
PPTX
DIABETIC KETOACIDOSIS IN CHILDREN by Dr.Gobinda
PPTX
DIABETES: DR. ANAND SINGH BHADORIYA (MBBS).pptx
PPTX
T2 dm with dka
PDF
DIABETES KETO ACIDOSIS, DKA IN CHILDREN.
DKA by Dr. A. Mandour.pptx
dkadrsyed2584-190602083813 (1).pptx
Diabetic Ketoacidosis
dkadrsyed2584-190602083813 (1).pdf
DKA Presentation in ICU.................
DKA Discussion Paediatrics.pptx
Diabetes+ketoacidosis
Presentation on diabetic Ketoacidosis DKA.pptx
DKA and HHS Abdullah Bani Issa aaaa.pptx
Hyperglycemic emergencies
DIABETIC KETOACIDOSIS. and ISPAD classification
Diabetic Ketoacidosis management in pediatrics
DM medical emergencies 25-10-2023.pptx
Dka diabetic ketoacidosis managment
DIABETIC KETOACIDOSIS IN CHILDREN by Dr.Gobinda
DIABETES: DR. ANAND SINGH BHADORIYA (MBBS).pptx
T2 dm with dka
DIABETES KETO ACIDOSIS, DKA IN CHILDREN.
Ad

Recently uploaded (20)

PDF
Dr. Jasvant Modi - Passionate About Philanthropy
PDF
Megan Miller Colona Illinois - Passionate About CrossFit
PPTX
ABG advance Arterial Blood Gases Analysis
PPTX
Nursing Care Aspects for High Risk newborn.pptx
PPT
KULIAH UG WANITA Prof Endang 121110 (1).ppt
PPTX
Medical aspects of impairment including all the domains mentioned in ICF
PDF
Dr Masood Ahmed Expertise And Sucess Story
PPTX
PEDIATRIC OSCE, MBBS, by Dr. Sangit Chhantyal(IOM)..pptx
PDF
Structure Composition and Mechanical Properties of Australian O.pdf
PPTX
PE and Health 7 Quarter 3 Lesson 1 Day 3,4 and 5.pptx
PPTX
AI_in_Pharmaceutical_Technology_Presentation.pptx
PPTX
different types of Gait in orthopaedic injuries
PDF
Khaled Sary- Trailblazers of Transformation Middle East's 5 Most Inspiring Le...
PDF
Pharmacology slides archer and nclex quest
PPTX
Basics of pharmacology (Pharmacology I).pptx
PPTX
General Pharmacology by Nandini Ratne, Nagpur College of Pharmacy, Hingna Roa...
PPTX
Pure O Obsessive Compulsive Disorder Presentation
PDF
A Brief Introduction About Malke Heiman
PDF
MECE & SCQA FRAMEWORKS, - Adding Innovation & Influencing Hospital & Super-Sp...
PPTX
Infection prevention and control for medical students
Dr. Jasvant Modi - Passionate About Philanthropy
Megan Miller Colona Illinois - Passionate About CrossFit
ABG advance Arterial Blood Gases Analysis
Nursing Care Aspects for High Risk newborn.pptx
KULIAH UG WANITA Prof Endang 121110 (1).ppt
Medical aspects of impairment including all the domains mentioned in ICF
Dr Masood Ahmed Expertise And Sucess Story
PEDIATRIC OSCE, MBBS, by Dr. Sangit Chhantyal(IOM)..pptx
Structure Composition and Mechanical Properties of Australian O.pdf
PE and Health 7 Quarter 3 Lesson 1 Day 3,4 and 5.pptx
AI_in_Pharmaceutical_Technology_Presentation.pptx
different types of Gait in orthopaedic injuries
Khaled Sary- Trailblazers of Transformation Middle East's 5 Most Inspiring Le...
Pharmacology slides archer and nclex quest
Basics of pharmacology (Pharmacology I).pptx
General Pharmacology by Nandini Ratne, Nagpur College of Pharmacy, Hingna Roa...
Pure O Obsessive Compulsive Disorder Presentation
A Brief Introduction About Malke Heiman
MECE & SCQA FRAMEWORKS, - Adding Innovation & Influencing Hospital & Super-Sp...
Infection prevention and control for medical students

DKA in children

  • 1. DIABETIC KETOACIDOSIS IN CHILDREN D:MH RADI SENIOR REGESTRAR OF PEDIATRICS
  • 2. DEFINITION • Hyperglycemia BG > 200 mg/dl (11 mmol/l) (young or partially treated children, pregnant adolescents may present with “euglycemic ketoacidosis”) • Venous pH <7.3 and/or bicarbonate <15 mmol/L • mild DKA pH <7.3 bicarbonate <15 • moderate pH <7.2 bicarbonate <10 • severe pH <7.1 bicarbonate < 5 • Glucosuria and ketonuria/ketonemia (β-HOB)
  • 3. INCIDENCE OF DKA AT ONSET • Wide geographic variation in DKA rates at diabetes onset: 15 -70% • More common in developing countries • DKA rates inversely related to incidence of type 1 diabetes
  • 4. RISK FACTORS FOR DKA AT ONSET • Age <12 yrs • No first degree diabetic relative • Lower socioeconomic status • High dose glucocorticoids, atypical antipsychotics, diazoxide and some immunosuppresive drugs • Poor access to medical care
  • 5. DKA IN CHILDREN WITH ESTABLISHED T1DM • The risk of DKA varies from 1:10 to 1:100 /p-yr • Poor metabolic control or previous DKA  risk • Adolescent girls • Children with psychiatric disorders, including those with eating disorders • Lower socio-economic status • Inappropriate interruption of insulin pump therapy
  • 6. PROPORTION OF CHILDREN WITH RECURRENT DKA 0 1 2+ • 60% of DKA episodes occurred in 5% of children who had 2 or more events # of DKA events 5%
  • 7. Diabetes Care 2006 29:1150-1159
  • 8. SIGNS OF DKA • Vomiting • Increased urination • Abdominal pain • Fruity odor to breath • Dry mouth and tongue • Drowsiness • Deep breathing • Coma • Death
  • 9. PHYSICAL EXAM • Perfusion • Vital Signs - including weight • Hydration • Mental Status • Evidence for insulin resistance
  • 10. CEREBRAL EDEMA • Know what to look for • Altered mental status/ severe headache • Recurrence of vomiting • Changes in pupil size, seizures, bradycardia • Clinical worsening despite improving lab values • CT/ MRI changes may not be seen in early cerebral edema
  • 11. TIME OF ONSET OF NEUROLOGICAL COMPROMISE (HOURS) 0 2 4 6 8 10 12 14 16 0-2.9 3-5.9 6-8.9 9-11.9 12-14.9 >15 # of patients Muir A, et al, Diab Care. July 2004 Timing of Onset of Cerebral Edema in DKA
  • 12. CALCULATIONS SERUM OSMOLALITY: 2[NA+K]+ (GLUCOSE/18) + BUN/2.8 SERUM NA: CORRECTED NA = MEASURED NA + (1.6)(GLUCOSE - 100)/100 ANION GAP: [NA] – ([CL]+[HCO3]) NORMALLY 12+/-2 MMOL/L
  • 13. TREATMENT • Consider ICU admission for closer monitoring if: • Severe DKA (pH < 7.1 or < 7.2 in young child) • Altered level of consciousness • Under age of 5 years • Increased risk for cerebral edema • Caution with meds that may alter mental status
  • 14. TREATMENT Monitoring • Management requires close attention to detail • Use a flowsheet to track vital signs labs, rates of insulin, fluids, dextrose • Neurological status • consider neuro checks q 1 hr • How does the patient look TO YOU? • Assess, reassess and then assess again
  • 15. FLUID THERAPY FOR DKA • Assume 10-15% dehydration • Begin with a 10-20 ml/kg bolus of NS • Replace calculated deficit evenly over 36-48 hours • Do not exceed 40ml’s/kg in the initial 4 hours, or 4 L/m squared in 24 hours
  • 16. DKA - FLUIDS • START BY ½ NS • K supplementation 20mEq/L K Acetate + 20mEq/L K Phosphate • Ionized calcium is low, phosphorous should not be given • early replacement and frequent monitoring • Bicarbonate therapy is rarely, if ever, indicated
  • 17. INSULIN THERAPY FOR DKA • IV infusion with basal rate 0.1 U/kg/hr • No initial insulin bolus – it will decrease time to correction of the glucose, but does not alter the time to correction of acidosis It may decrease the serum osmolality more rapidly than desirable • Ideal glucose decline is about 100 mg%/hr • Continue insulin until urinary (blood) ketones are cleared
  • 18. POTASSIUM • Add potassium when K< 5 and with urination • K >5.5 – no potassium in IVF • K 4.5 – 5.5 – 20 meq/L K+ • K <4.5 – 40 meq/L K+
  • 19. USE OF BICARBONATE IN DKA • Bicarbonate should be used only when there is severe depression of the circulatory system or cellular metabolism... • Not recommended unless pH <7.0, not even then, unless above true
  • 20. TREATMENT OF CEREBRAL EDEMA • Mannitol: 1 gram/ kg IV over 30 minutes • Elevate the head of the bed • Decrease IVF rate and insulin infusion rate • Pediatric ICU management • Do not delay treatment until radiographic evidence
  • 21. SUCCESSFUL MANAGEMENT • Careful attention to detail • Careful record keeping • A detailed flow chart is essential • Following the data recorded is also essential • Repeated examination of the patient